LOINC Code 96450-2: Hepatotocellular carcinoma risk [Score] GALAD

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Hepatocellular carcinoma risk. It is commonly used with the system or sample type ^Patient.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Observation
• Method: GALAD

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Hepatotocellular carcinoma risk [Score] GALAD
• Hepatocellular carcinoma risk
• The GALAD score provides the probability of a patient having hepatocellular carcinoma (HCC). It is calculated based on gender, age, alpha-fetoprotein (AFP)-L3, AFP, and des-gamma-carboxy prothrombin [DCP], and higher GALAD model scores correlate with increased risk of HCC. The GALAD model is reported to be more accurate in diagnosing HCC compared to the use of the individual markers.
• Chemistry; Hep Ca Risk; Hepatology; Liver; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Scre

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions